Cargando…
Protein kinase C(ι) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
We report that atypical protein kinase Cι (PKCι) is an oncogenic driver of glioblastoma (GBM). Deletion or inhibition of PKCι significantly impairs tumor growth and prolongs survival in murine GBM models. GBM cells expressing elevated PKCι signaling are sensitive to PKCι inhibitors, whereas those ex...
Autores principales: | Kenchappa, Rajappa S., Liu, Yi, Argenziano, Michael G., Banu, Matei A., Mladek, Ann C., West, Rita, Luu, Amanda, Quiñones-Hinojosa, Alfredo, Hambardzumyan, Dolores, Justilien, Verline, Leitges, Michael, Sarkaria, Jann N., Sims, Peter A., Canoll, Peter, Murray, Nicole R., Fields, Alan P., Rosenfeld, Steven S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845019/ https://www.ncbi.nlm.nih.gov/pubmed/34818553 http://dx.doi.org/10.1016/j.celrep.2021.110054 |
Ejemplares similares
-
Ect2 links the PKCι-Par6α Complex to Rac1 Activation and Cellular Transformation
por: Justilien, Verline, et al.
Publicado: (2009) -
PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
por: Wang, Yin, et al.
Publicado: (2016) -
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma
por: Kenchappa, Rajappa S., et al.
Publicado: (2022) -
Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma
por: Gampa, Gautham, et al.
Publicado: (2020) -
Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma
por: Cheng, Yim Ling, et al.
Publicado: (2023)